Are SARS-CoV-2 specific antibodies a correlate for protection?)

Project Details


The objectives of this study are (1) to determine the ex vivo neutralizing capacity and the longevity of SARS-CoV-2-specific Ab responses and (2) to measure the MBC responses in a cohort of health care workers (HCW) recovering from severe, mild or asymptomatic infection. By focusing on HCW, a population that is at risk for re-infection during a second epidemic wave, we also aim to correlate nAb levels with protection.
Effective start/end date22/05/2031/05/23


  • Research Fund - Flanders: €115,770.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.